Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,425 | $5,175 | $4,728 | $5,357 |
| % Growth | -14.5% | 9.5% | -11.7% | – |
| Cost of Goods Sold | $3,037 | $3,136 | $3,176 | $3,235 |
| Gross Profit | $1,388 | $2,039 | $1,552 | $2,122 |
| % Margin | 31.4% | 39.4% | 32.8% | 39.6% |
| R&D Expenses | $179 | $172 | $189 | $209 |
| G&A Expenses | $434 | $1,882 | $1,591 | $1,788 |
| SG&A Expenses | $1,041 | $2,462 | $2,262 | $2,480 |
| Sales & Mktg Exp. | $607 | $580 | $671 | $692 |
| Other Operating Expenses | $0 | $0 | $0 | -$3 |
| Operating Expenses | $1,220 | $2,634 | $2,451 | $2,689 |
| Operating Income | $168 | -$595 | -$899 | -$567 |
| % Margin | 3.8% | -11.5% | -19% | -10.6% |
| Other Income/Exp. Net | -$8 | -$11 | $1 | -$5 |
| Pre-Tax Income | $160 | -$606 | -$898 | -$572 |
| Tax Expense | -$29 | -$71 | -$71 | $116 |
| Net Income | $189 | -$535 | -$827 | -$688 |
| % Margin | 4.3% | -10.3% | -17.5% | -12.8% |
| EPS | 0.032 | -0.091 | -0.14 | -0.12 |
| % Growth | 135.2% | 35.1% | -16.7% | – |
| EPS Diluted | 0.032 | -0.091 | -0.14 | -0.12 |
| Weighted Avg Shares Out | 5,894 | 5,894 | 5,817 | 5,806 |
| Weighted Avg Shares Out Dil | 5,894 | 5,894 | 5,817 | 5,806 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $413 | $0 | $664 | $551 |
| EBITDA | $584 | -$595 | -$235 | -$16 |
| % Margin | 13.2% | -11.5% | -5% | -0.3% |